Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.1.145 extracted from

  • Zhao, Y.; Jiang, H.; Gu, M.; Zu, C.; Zheng, X.
    Gemcitabine resistance in triple-negative breast cancer cells can be reverted by Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol (2020), Oncol. Lett., 20, 247 .
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine the enzyme is a potential candidate for reversing acquired gemcitabine resistance in triplex1enegative breast cancer cells, which may form the basis of strategies for the treatment of patients with drugx1eresistant triplex1enegative breast cancer Drosophila melanogaster

Cloned(Commentary)

Cloned (Comment) Organism
expressed in MDA-MB-231 and MDA-MB-231R cells Drosophila melanogaster

Localization

Localization Comment Organism GeneOntology No. Textmining

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
ATP + a 2'-deoxyribonucleoside Drosophila melanogaster
-
ADP + a 2'-deoxyribonucleoside 5'-phosphate
-
?

Organism

Organism UniProt Comment Textmining
Drosophila melanogaster
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
ATP + a 2'-deoxyribonucleoside
-
Drosophila melanogaster ADP + a 2'-deoxyribonucleoside 5'-phosphate
-
?

Synonyms

Synonyms Comment Organism
deoxyribonucleoside kinase
-
Drosophila melanogaster
dNK
-
Drosophila melanogaster